Found 8 matching trials
Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
EARLY_PHASE1The goal of this clinical trial is to study the safety, feasibility, histol...
Location
Hospital of the University of Pennsylvania
Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers
PHASE2The goal of this clinical trial is to etablish whether adding Mitazalimab t...
Location
Institut de cancérologie de l'Ouest - Site Paul Papin
ADC-1013 First-in-Human Study
PHASE1The purpose of this study is to determine whether ADC-1013 (an agonistic hu...
Location
Center for Cancer Research, Department of Oncology, Herlev Hospital
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
PHASE1The primary purpose of the study is to determine the recommended Phase 2 do...
Location
Multiple Locations
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
PHASE2Phase II, open-label, single-arm study of CD40/Dectin-1 immunotherapy as ma...
Location
Hospital of the University of Pennsylvania
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
PHASE1This is a phase I study of an agonistic CD40 antibody (mitazalimab) injecte...
Location
UCSD Moores Cancer Center
MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)
PHASE1Pancreatic cancer is expected to be the second leading cause of cancer-rela...
Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients
PHASE1Phase 1b/2 study to assess the safety and efficacy of mitazalimab in combin...
Status
Active Not Recruiting
Location
Cliniques Universitaires St-Luc